William A. D’angelo

William A. D’angelo

Auto-generated profile, based on publicly available information

William A. D’angelo

McGowan Institute for Regenerative Medicine, University of Pittsburgh, 450 Technology Drive, Pittsburgh, PA 15219, USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2024 in Science Advances
Verified
Journal Article
Open access
RLRunzhi Liao
Runzhi Liao
MDMarley J. Dewey
Marley J. Dewey
JRJiayang Rong
Jiayang Rong
SJScott A. Johnson
Scott A. Johnson
WDWilliam A. D’angelo
William A. D’angelo
SBStephen Badylak
Stephen Badylak
Aseptic loosening of orthopedic implants is an inflammatory disease characterized by immune cell activation, chronic inflammation, and destruction of periprosthetic bone, and is one of the leading reasons for prosthetic failure, affecting 12% of total joint arthroplasty patients. Matrix-bound nanovesicles (MBVs) are a subclass of extracellular vesicle recently shown to mitigate inflammation in preclinical models of rheumatoid arthritis and influenza-mediated “cytokine storm.” The molecular mechanism of these anti-inflammatory properties is only partially understood. The objective of the present study was to investigate the effects of MBV on RANKL-induced osteoclast formation in vitro and particulate-induced osteolysis in vivo. Results showed that MBV attenuated osteoclast differentiation and activity by suppressing the NF-κB signaling pathway and downstream NFATc1, DC-STAMP, c-Src, and cathepsin K expression. In vivo, local administration of MBV attenuated ultrahigh molecular weight polyethylene particle-induced osteolysis, bone reconstruction, and periosteal inflammation. The results suggest that MBV may be a therapeutic option for preventing periprosthetic loosening.

13 February 2026 in Science Advances
Verified
Journal Article
Open access
HCHéctor Capella-Monsonís
Héctor Capella-Monsonís
JRJiayang Rong
Jiayang Rong
BCBharadwaj Chirravuri
Bharadwaj Chirravuri
WDWilliam D’ANgelo
William D’ANgelo
HTHēth R. Turnquist
Hēth R. Turnquist
SBStephen Badylak
Stephen Badylak
Extracellular vesicles (EV) represent a conserved and highly efficient mechanism for cell-to-cell communication. Matrix-bound nanovesicles (MBV) are a recently identified type of EV embedded within the extracellular matrix with potent local and systemic immunomodulatory effects on myeloid cells. These effects are durable and last beyond the predicted life span of differentiated myeloid cells such as macrophages. The present study investigated MBV-directed epigenetic modification in myeloid precursors as a potential explanation for their prolonged immunomodulatory effects. Flow cytometry and ATAC sequencing studies show that MBV are internalized by myeloid cell progenitors in the bone marrow and in macrophages after terminal differentiation. This internalization is coincident with epigenetic changes that are associated with modulation of macrophage responses to inflammatory stimuli. Furthermore, MBV treatment differentially alters chromatin accessibility as a function of cell differentiation state (i.e., myeloid progenitor versus macrophage). The present study shows the epigenetic effects of MBV on myeloid cells, representing a potential avenue to exploit the therapeutic potential of biologic scaffold materials.

10 June 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
MBMarianna Barbuto
Marianna Barbuto
AAArianna Adamo
Arianna Adamo
BCBeatrice di Caccamo
Beatrice di Caccamo
Laura Modica de MohacLaura Modica de Mohac
Laura Modica de Mohac
TFTaro Fujii
Taro Fujii
ADAntonio D&Apos;Amore
Antonio D&Apos;Amore
Small-diameter vascular grafts remain a major unmet clinical need due to their susceptibility to thrombosis, intimal hyperplasia, and poor long-term patency. Here, we introduce a biomimetic three-layered vascular graft (3LVG) designed to recapitulate the functional heterogeneity of native arteries through a structural gradient that guides host cell infiltration and vascular remodeling. The graft integrates an electrospun poly(carbonate-urethane) urea (PCUU) layer, a bioactive decellularized extracellular matrix medial layer, and a porous thermally induced phase separation PCUU layer. The combination of these techniques produced layers with different pore size ranges to preferentially promote either adventitial-derived (ACR) or intimal-derived (ICR) cell recruitment. Implanted as abdominal aortic interposition grafts in rats, ACR grafts showed superior in vivo performance, with 100% patency at 4 and 8 weeks, whereas ICR grafts demonstrated reduced patency associated with anastomotic intimal hyperplasia. ACR grafts also exhibited enhanced endothelialization, greater adventitial cell infiltration, increased collagen deposition, more abundant vasa vasorum formation, and compliance comparable to native vessels at 8 weeks. These findings demonstrate that bioinspired structural heterogeneity can direct host remodeling, reduce maladaptive luminal responses, and improve graft performance. This work identifies structural gradient-driven cell recruitment as a promising design principle for next-generation small-diameter tissue-engineered vascular grafts.